Adfalcivax vaccine: The risk of many major diseases is increasing worldwide, in which cases of malaria and dengue spread from mosquitoes after cancer and diabetes are constantly found. During the rainy season, the number of mosquitoes flourish is more. Amidst the fear of these diseases, recently, the Council for Medical Research (ICMR) of India (ICMR) has created a new Mahriaxin Adafalcivax in collaboration with the National Institute of Immunology (DBT-NIII), in collaboration with the National Institute of Immunology (DBT-NIII), in collaboration with the Regional Medical Research Center (RMRCBB) and National Institute of Malaria Research (NIMR) in Bhubaneswar. Reduces At the same time, it prevents diseases like malaria. Let’s know everything about the vaccine…
Malaria The recently prepared vaccine is named Adfalcivax Vaccine which helps in fighting every stage in malaria. This vaccine attacks two important stages of malaria parasites. In the first stage, when the parasite spreads infection in the human body and the second stage when the disease through mosquitoes reaches from one human to another. it Vaccine Along with protecting against the disease, the disease prevents spreading throughout the area. Trial has been done before using this vaccine. According to this, this vaccine has proved effective in the initial Tests on animals.
Apart from this, this vaccine has so far been considered better than vaccines such as RTS, S/AS01 and R21/Matrix-M in the market. It is being told that in making this vaccine, safe bacteria named ‘Lactococcus lactis’ were used, which is already known in the vaccine development. It has a strong vaccine by combining effective elements against two different stages. It does not spoil for 9 months.
Let me tell you, in addition to other vaccines, this new vaccine of malaria works on two phases. This not only reduces the risk of malaria for a person, but also stops the spread of disease through mosquitoes. Apart from this, this vaccine also reduces the parasite’s attempt to dodge the body’s immunity and gives prolonged protection. It is known about this vaccine that, Adfalcivax is currently in the initial development stage which will take time to reach people. After several trials, this vaccine will reach people after about 7 years. In this, human testing will come in the market only after the final approval received after conducting a mass trial.
